Skip to the content
Seraxislogo darklogo light
  • Home
  • Technology
  • Pipeline
  • About
    • Leadership
    • Press Releases
    • In the News
    • Publications & Presentations
    • Contact Us
Search
Seraxis
  • Home
  • Technology
  • Pipeline
  • About
    • Leadership
    • Press Releases
    • In the News
    • Publications & Presentations
    • Contact Us
HomePresentationConcise Review: Lessons Learned from Islet Transplant Clinical Trials in Developing Stem Cell Therapies for Type 1 Diabetes.
Presentation

Concise Review: Lessons Learned from Islet Transplant Clinical Trials in Developing Stem Cell Therapies for Type 1 Diabetes.

admin
November 12, 2018
Welsch CA, Rust WL, Csete M. Concise Review: Lessons Learned from Islet Transplant Clinical Trials in Developing Stem Cell Therapies for Type 1 Diabetes. Stem Cells Transl Med. 2018 Nov 12.

About Seraxis, Inc.

Seraxis is a private biotechnology company launched in 2013 and located in Germantown, Maryland. The Seraxis mission is to develop a practical and potent cell replacement therapy for insulin-dependent diabetes.

Share share
  • .face-icon{fill:#fff;}
  • .tw-icon{fill:#fff;}
  • .ln-icon{fill:#fff;}
  • .pn-icon{fill:#fff;}
Next post
Cell Replacement Therapy for Insulin-Dependent Diabetes: Maintaining Islet Architecture and Distribution After Graft.

Related articles

Sernova Webinar
Presentation
Sernova Biotherapeutics Shareholder Webinar
admin
September 11, 2026
The Diabetes Nerd Podcast with WIll Rust
Presentation
The Diabetes Nerd Podcast: Real Science with Seraxis CEO Will Rust
admin
September 25, 2026
Presentation
Evercore ISI 2024 Emerging Private Biotech Conference.
admin
February 29, 2024
Seraxis, Inc.

Seraxis, Inc | 20400 Centrury Blvd, Suite 150 | Germantown, MD 20874

Home

Technology

Publications & Presentations

Pipeline

About

Press Releases

Contact Us

© 2026 Seraxis, Inc. All Rights Reserved

Back to top Drag
w
  • Services
  • Careers
  • Contact Us